Informations générales (source: ClinicalTrials.gov)
Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy
Interventional
N/A
Institut Mutualiste Montsouris (Voir sur ClinicalTrials)
mars 2017
août 2018
29 juin 2024
The objective of this study is to determine whether stapling adversely affects the
pulmonary parenchyma and the vascularisation of the adjacent segments. The aim of our
work is to explore by thoracic densitometry with contrast the spared segments after
stapling of the intersegmental plan following a thoracoscopic segmentectomy, 3 or 6
months post-surgery. the investigator will assess venous drainage and the arterial
vascularisation of the remaining segments, possible modifications of the adjacent
parenchyma and whether there is a defect of pleuro-pulmonary adhesion (residual
pneumothorax).
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| INSTITUT MUTUALISTE MONTSOURIS | Isabelle SAURET | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Enrolment in the study will be offered to all patients having undergone a programmed
scheduled video-assisted thoracoscopic segmentectomy, whatever the aetiology.
- Men or women aged 18 years or greater
- Absence of severe hepatic insufficiency
- signed and dated informed consent
- candidate for segmentectomy
- Registration in a national healthcare system.
- Women of child-bearing age using effective oral or barrier contraception
- Enrolment in the study will be offered to all patients having undergone a programmed
scheduled video-assisted thoracoscopic segmentectomy, whatever the aetiology.
- Men or women aged 18 years or greater
- Absence of severe hepatic insufficiency
- signed and dated informed consent
- candidate for segmentectomy
- Registration in a national healthcare system.
- Women of child-bearing age using effective oral or barrier contraception
- Proven intolerance to iodinated contrast agents
- Know allergy or non-controlled asthma - pregnancy
- Severe hepatic insufficiency (creatinine clearance < 30ml/min, by Cockroft's method)
- Pregnant or breastfeeding women
- Patients under trusteeship or curators
- Diabetic patients or patients receiving oral antidiabetic medication